Co-administration of the RSV and shingles adjuvanted vaccines was well tolerated, with acceptable reactogenicity and safety ...

Some people experience PHN symptoms for the rest of their lives. Older adults and people with weakened immune systems are most likely to have PHN. If you do not develop PHN, you can expect to start ...

The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can ...

Responding to rising mpox cases in Africa, the World Health Organization declared a public health emergency of international ...

The FDA has approved Ebglyss (lebrikizumab-lbkz), a new biologic treatment for moderate-to-severe atopic dermatitis in people ...

Ghosts might think they're the scariest thing fall has to offer, but they haven't seen my dry, cracked hands yet. View Entire Post › ...

When Nancy Greeley was in her 50s, her sister, an infectious-disease specialist at the University of Rochester, told her to ...

British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...

Aussies who are classified as 'moderate to high risk' and are aged between 18 and 64 now qualify for the immunisation.

Closer takes a look at five vaccines you should get after you turn 50 to help protect against illness. Shingles: “The first ...